Panacea Index Logo

Command Palette

Search for a command to run...

How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes.

Diabetic medicine : a journal of the British Diabetic Association
March 1, 2020
F Pouwer et al. (5 authors)
Historical ArticleJournal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to summarize and discuss the links between depression and diabetes, including the effectiveness of mindfulness-based cognitive therapy as a treatment for depression in individuals with diabetes.

Results Summary

The study found that mindfulness-based cognitive therapy is one of the effective treatments for depression in individuals with diabetes, alongside other interventions like antidepressant medication and cognitive-behavioral therapy. However, the abstract does not provide specific details on the magnitude of mindfulness's effects compared to other treatments.

Population

Individuals with type 1 or type 2 diabetes who also have depression.

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (10)
InterventionDirectionEndpointPopulationDosageImpactClaim #
-
increase
depression
people with type 1 or type 2 diabetes
-
occurs more frequently
#1
-
increase
less optimal self-care behaviours
people with diabetes
-
associated with
#2
-
increase
suboptimal glycaemic control
people with diabetes
-
associated with
#3
-
increase
impaired quality of life
people with diabetes
-
associated with
#4
-
increase
incident micro- and macrovascular diseases
people with diabetes
-
associated with
#5
-
increase
elevated mortality rates
people with diabetes
-
associated with
#6
antidepressant medication
decrease
depression in diabetes
people with diabetes
-
can be treated with
#7
cognitive-behavioural therapy (individual, group-based or web-based)
decrease
depression in diabetes
people with diabetes
-
can be treated with
#8
mindfulness-based cognitive therapy
decrease
depression in diabetes
people with diabetes
-
can be treated with
#9
stepped care
decrease
depression in diabetes
people with diabetes
-
can be treated with
#10
Abstract

This narrative review of the literature provides a summary and discussion of 25 years of research into the complex links between depression and diabetes. Systematic reviews have shown that depression occurs more frequently in people with type 1 or type 2 diabetes compared with people without diabetes. Currently, it remains unclear whether depression is also more common in people with impaired glucose metabolism or undiagnosed type 2 diabetes compared with people without diabetes. More prospective epidemiological research into the course of depression and an exploration of mechanisms in individuals with diabetes are needed. Depression in diabetes is associated with less optimal self-care behaviours, suboptimal glycaemic control, impaired quality of life, incident micro- and macrovascular diseases, and elevated mortality rates. Randomized controlled trails concluded that depression in diabetes can be treated with antidepressant medication, cognitive-behavioural therapy (individual, group-based or web-based), mindfulness-based cognitive therapy and stepped care. Although big strides forward have been made in the past 25 years, scientific evidence about depression in diabetes remains incomplete. Future studies should investigate mechanisms that link both conditions and test new diabetes-specific web- or app-based interventions for depression in diabetes. It is important to determine whether treatment or prevention of depression prevents future diabetes complications and lowers mortality rates.

Medical Subject Headings (MeSH)
Behavioral ResearchCognitive Behavioral TherapyDepressionDiabetes MellitusHistory, 20th CenturyHistory, 21st CenturyHumansPsychologyQuality of LifeRandomized Controlled Trials as TopicTime Factors
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations36
Citations/Year7.2
Relative Citation Ratio2.69
NIH Percentile82.6%
Research Impact Scores
APT Score0.95
Weight Score2.54
Normalized Score0.66
Related Supplements